Cargando…
Biocompatible Aza-BODIPY-Biotin Conjugates for Photodynamic Therapy of Cancer
[Image: see text] With an objective to develop efficient photosensitizers to cancerous tissues, we synthesized two novel biocompatible sensitizers based on aza-BODIPYs incorporated with heavy atoms and biotin moieties. The bioconjugates DPR2a and DPR2b exhibited a favorable absorption range (600–750...
Autores principales: | Dutta, Dhiraj, Nair, Rajshree R., Mangalath, Sreejith, Nair, S. Asha, Joseph, Joshy, Gogoi, Pranjal, Ramaiah, Danaboyina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373210/ https://www.ncbi.nlm.nih.gov/pubmed/37521632 http://dx.doi.org/10.1021/acsomega.3c02416 |
Ejemplares similares
-
Picolyl Porphyrin Nanostructures as a Functional Drug
Entrant for Photodynamic Therapy in Human Breast Cancers
por: Marydasan, Betsy, et al.
Publicado: (2019) -
Aza-BODIPY based carbonic anhydrase IX: Strategy to overcome hypoxia limitation in photodynamic therapy
por: Pewklang, Thitima, et al.
Publicado: (2022) -
Effect of the Aza-N-Bridge
and Push–Pull Moieties:
A Comparative Study between BODIPYs and Aza-BODIPYs
por: Schäfer, Clara, et al.
Publicado: (2022) -
Application of
aza-BODIPY as a Nitroaromatic Sensor
por: Sadikogullari, Bleda Can, et al.
Publicado: (2023) -
Chlorin e6-Biotin Conjugates for Tumor-Targeting Photodynamic Therapy
por: Liu, Wei, et al.
Publicado: (2021)